Showing results (371-380 of 387) with videos related to

Sort By:
Pageof 39
Pediatric Blood & Cancer|May 21, 2021
Treatment of posttransplant lymphoproliferative disorder with poor prognostic features in children and young adults: Short-course EPOCH regimens are safe and effectiveJeremy D Rubinstein, Rachana Shah, Erin H Breese, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|January 22, 2021
Generation of an Allelic Series at the Ahr Locus Using an Edited Recombinant ApproachRachel H Wilson, Patrick R Carney, Edward Glover, et al.
Blood Advances|November 20, 2020
Virus-specific T-cell therapy to treat BK polyomavirus infection in bone marrow and solid organ transplant recipientsAdam S Nelson, Daria Heyenbruch, Jeremy D Rubinstein, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 21, 2024
Third-party virus-specific T cells for the treatment of double-stranded DNA viral reactivation and posttransplant lymphoproliferative disease after solid organ transplantRuby Khoury, Michael S Grimley, Adam S Nelson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 13, 2001
Collection of genomic DNA from adults in epidemiological studies by buccal cytobrush and mouthwashM García-Closas, K M Egan, J Abruzzo, et al.
Transplantation and Cellular Therapy|November 17, 2021
Off-the-Shelf Third-Party Virus-Specific T Cell Therapy to Treat JC Polyomavirus Infection in Hematopoietic Stem Cell Transplantation RecipientsJeremy D Rubinstein, Sonata Jodele, Daria Heyenbruch, et al.
Leukemia|October 31, 2022
Outcome of chimeric antigen receptor T-cell therapy following treatment with inotuzumab ozogamicin in children with relapsed or refractory acute lymphoblastic leukemiaValeria Ceolin, Erica Brivio, Harm van Tinteren, et al.
Transplantation and Cellular Therapy|May 4, 2026
Third-Party Viral Specific T cells for Immunocompromised Hosts and Access Barriers: A Review and Commentary by an Expert Panel from ASTCTStella M Davies, Emily Blyth, Catherine M Bollard, et al.
Genome Biology|September 7, 2020
The Tug1 lncRNA locus is essential for male fertilityJordan P Lewandowski, Gabrijela Dumbović, Audrey R Watson, et al.
Blood Advances|February 2, 2022
Scheduled administration of virus-specific T cells for viral prophylaxis after pediatric allogeneic stem cell transplantJeremy D Rubinstein, Carolyn Lutzko, Thomas Leemhuis, et al.
Pageof 39